Giuseppina Mattace Raso Selected Research

butyramide

1/2017	An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis.
1/2017	Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice.
1/2016	Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice.
1/2013	Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppina Mattace Raso Research Topics

Disease

16	Inflammation (Inflammations) 06/2022 - 01/2008
6	Obesity 01/2022 - 09/2014
6	Insulin Resistance 01/2020 - 01/2013
5	Neuroinflammatory Diseases 06/2022 - 11/2016
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
4	Fatty Liver 01/2020 - 01/2013
3	Glioma (Gliomas) 06/2016 - 03/2006
2	Parkinson Disease (Parkinson's Disease) 06/2022 - 11/2016
2	Neuroblastoma 01/2022 - 11/2016
2	Colitis 01/2017 - 06/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017 - 06/2015
2	Hyperalgesia 01/2016 - 06/2009
2	Pain (Aches) 01/2016 - 06/2009
2	Hypertension (High Blood Pressure) 01/2015 - 10/2013
1	Dysbiosis 06/2022
1	Mental Fatigue 01/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Seizures (Absence Seizure) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2020
1	Epilepsy (Aura) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Shock 01/2017
1	Hyperglycemia 01/2017
1	Hypothyroidism 07/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Visceral Pain 01/2016
1	Chronic Pain 01/2016
1	Non-alcoholic Fatty Liver Disease 01/2013

Drug/Important Bio-Agent (IBA)

5	Butyrates (Butyrate)IBA 06/2022 - 01/2013
5	Butyric Acid (Butanoic Acid)IBA 06/2022 - 01/2013
5	palmidrolIBA 01/2022 - 06/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2013
4	CytokinesIBA 01/2022 - 01/2014
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2015
4	LeptinIBA 01/2018 - 03/2006
4	butyramideIBA 01/2017 - 01/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2018
3	LigandsIBA 01/2020 - 10/2013
2	Oxidopamine (6 Hydroxydopamine)IBA 06/2022 - 11/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2016
2	LipidsIBA 01/2020 - 01/2018
2	Insulin (Novolin)FDA Link 01/2020 - 01/2018
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 11/2018
2	Hormones (Hormone)IBA 01/2018 - 11/2015
2	Dextrans (Dextran)FDA Link 01/2017 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 11/2016 - 06/2016
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2016 - 03/2006
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Glucosamine (Dona)IBA 01/2022
1	LycopeneIBA 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	AntioxidantsIBA 01/2019
1	N-oleoylethanolamineIBA 01/2018
1	SugarsIBA 01/2018
1	Olive OilIBA 01/2017
1	SodiumIBA 01/2017
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2017
1	AdipokinesIBA 01/2017
1	PolyphenolsIBA 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2016
1	NeurosteroidsIBA 06/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016
1	Leptin ReceptorsIBA 11/2015
1	Therapeutic UsesIBA 06/2015
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 06/2015
1	Drinking WaterIBA 06/2015
1	Polychlorinated Biphenyls (PCBs)IBA 09/2014
1	Angiotensin IIIBA 10/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2013
1	AmidesIBA 01/2013
1	Transaminases (Aminotransferases)IBA 01/2013
1	IronIBA 01/2013
1	NF-kappa B (NF-kB)IBA 06/2009
1	PPAR alphaIBA 06/2009
1	Biological ProductsIBA 06/2009
1	CarrageenanIBA 06/2009
1	Peroxisome ProliferatorsIBA 06/2009
1	InterferonsIBA 01/2008
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2008
1	MelatoninIBA 01/2008
1	LipopolysaccharidesIBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 01/2008

Therapy/Procedure

3	Therapeutics 01/2021 - 06/2015
1	Oral Administration 01/2016